Badarny Samih, Nassar Rima, Badarny Yazid
Neurology Department, Galilee Medical Center, Nahariya 221001, Israel.
Bar Ilan Faculty of Medicine, Zafed 1311502, Israel.
J Clin Med. 2023 Feb 14;12(4):1498. doi: 10.3390/jcm12041498.
Tardive syndrome (TS) refers to persistent hyperkinetic, hypokinetic, and sensory complaints appearing after chronic neuroleptics and other dopamine receptor-blocking agents (DRBAs). It is defined as involuntary movements, often rhythmic, choreiform, or athetoid, involving the tongue, face, extremities, and sensory urges such as akathisia and lasts for a few weeks. TS develops in association with neuroleptic medication usage for a few months at least. There is usually a delay between the initiation of the causative drug and the onset of abnormal movements. However, it was soon noted that TS can also develop early, even days or weeks after DRBAs begin. However, the longer the exposure, the greater the risk of developing TS. Tardive dyskinesia, dystonia, akathisia, tremor, and parkinsonism are frequent phenomenologies of this syndrome.
迟发性综合征(TS)是指在长期使用抗精神病药物及其他多巴胺受体阻断剂(DRBAs)后出现的持续性运动亢进、运动减退及感觉异常。它被定义为非自主运动,通常呈节律性、舞蹈样或手足徐动样,累及舌头、面部、四肢,以及如静坐不能等感觉冲动,持续数周。TS至少在使用抗精神病药物数月后发生。致病药物开始使用与异常运动发作之间通常有一段延迟。然而,很快人们就注意到TS也可能早期发生,甚至在DRBAs开始使用数天或数周后。然而,暴露时间越长,发生TS的风险就越大。迟发性运动障碍、肌张力障碍、静坐不能、震颤和帕金森症是该综合征常见的表现形式。